Clinical trial
BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing…
NCT00252200 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00252200 |
|---|---|
| Title | BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery. |
| Official title | Low Dose Continuous Infusion of BNP (Nesiritide) in the Prevention of Renal Insufficiency Post Cardiopulmonary Bypass Cardiac Surgery. |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Scios, Inc. Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Kidney Failure |
| Intervention type | Drug |
| Interventions | Neseritide |
| Enrollment | 40 |
| Start date | Mar 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Nov 11, 2005 |
| Last update posted | Sep 23, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: